Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants

Study Overview
=================
Brief Summary
-----------------
RATIONALE: Collecting and storing samples of blood from patients with cancer and healthy participants to test in the laboratory may help the study of cancer in the future. PURPOSE: This study is collecting and storing samples of blood from patients with pancreatic cancer and healthy participants.

Detailed Description
-----------------
OBJECTIVES: Establish a central pancreatic cancer specimen (including serum and peripheral blood lymphocytes) repository to serve as a resource for current or future scientific studies. Utilize the clinical database to perform clinicopathologic correlation with the results of those studies. Test new hypotheses as they emerge. OUTLINE: This is a prospective study. Blood is collected from patients with pancreatic cancer at baseline and then every 3-6 months for up to 2 years. All other participants have blood collected at baseline and complete questionnaires at baseline and then every 3-6 months for up to 2 years. Serum and peripheral blood lymphocytes obtained from the blood samples are frozen and stored. PROJECTED ACCRUAL: A total of 200 patients and 200 other participants will be accrued for this study.

Official Title
-----------------
Pancreatic Cancer Serum and Peripheral Blood Lymphocyte Repository

Conditions
-----------------
Pancreatic Cancer

Intervention / Treatment
-----------------
* Other: This is a non-intervention study for all groups.
* Other: study of socioeconomic and demographic variables


Participation Criteria
=================
Eligibility Criteria
-----------------
DISEASE CHARACTERISTICS: Meets 1 of the following criteria: Histologically confirmed pancreatic malignant neoplasm Serologically or image-confirmed diagnosis of pancreatitis or nonmalignant pancreatic disease Healthy, at-risk participant meeting the following criteria: Smoker, diabetic, and/or has a family history of pancreatic cancer Healthy participant (no history of cancer) PATIENT CHARACTERISTICS: Not specified PRIOR CONCURRENT THERAPY: Not specified

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 120 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Healthy individuals<br> | Other: This is a non-intervention study for all groups.<br>* This is a non-intervention study.<br>Other: study of socioeconomic and demographic variables<br>* Non-intervention study.<br>|
| At risk individuals<br> | Other: This is a non-intervention study for all groups.<br>* This is a non-intervention study.<br>Other: study of socioeconomic and demographic variables<br>* Non-intervention study.<br>|
| Cancer patients<br> | Other: This is a non-intervention study for all groups.<br>* This is a non-intervention study.<br>Other: study of socioeconomic and demographic variables<br>* Non-intervention study.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Establishment of a central pancreatic cancer specimen repository |  | No time frame | 
| Utilization of the clinical database to perform clinicopathologic correlation with the results of current or future scientific studies |  | No time frame | 
| Test new hypotheses as they emerge |  | No time frame | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
adenocarcinoma of the pancreas, recurrent pancreatic cancer, stage I pancreatic cancer, stage II pancreatic cancer, stage III pancreatic cancer, stage IV pancreatic cancer